# Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy

> **NCT01097811** · NA · UNKNOWN · sponsor: **UPECLIN HC FM Botucatu Unesp** · enrollment: 20 (actual)

## Conditions studied

- Hepatic Encephalopathy
- Hypertension, Portal
- Liver Cirrhosis

## Interventions

- **DRUG:** Erythromycin
- **DRUG:** Neomycin

## Key facts

- **NCT ID:** NCT01097811
- **Lead sponsor:** UPECLIN HC FM Botucatu Unesp
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** 2010-06
- **Final completion:** 2010-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2010-04-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01097811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01097811, "Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01097811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*